| 000 | 01481 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513132333.0 | ||
| 264 | 0 | _c19980108 | |
| 008 | 199801s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/(sici)1097-0215(19971210)73:6<875::aid-ijc19>3.0.co;2-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrodowicz, T | |
| 245 | 0 | 0 |
_aSoluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cDec 1997 |
||
| 300 |
_a875-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aAntibody-Dependent Cell Cytotoxicity |
| 650 | 0 | 4 |
_aBreast _xcytology |
| 650 | 0 | 4 |
_aBreast Neoplasms _ximmunology |
| 650 | 0 | 4 | _aCell Division |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCulture Media, Conditioned |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xanalysis |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aWiltschke, C | |
| 700 | 1 | _aBudinsky, A C | |
| 700 | 1 | _aKrainer, M | |
| 700 | 1 | _aSteger, G G | |
| 700 | 1 | _aZielinski, C C | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 73 _gno. 6 _gp. 875-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0215(19971210)73:6<875::aid-ijc19>3.0.co;2-3 _zAvailable from publisher's website |
| 999 |
_c9369345 _d9369345 |
||